Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 randomized placebo-controlled dose-finding study of Allocetra-OTS in adults with sepsis and organ dysfunction
MOH_2020-11-04_009434Phase 2Completed
- Sponsor
- Anelixis Therapeutics
- Start
- Aug 2020
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of Allocetra in sepsis (4 arms), sponsored by Anelixis Therapeutics. Started Aug 2020; status: completed.
02
Drugs
Allocetra
03
Conditions
sepsis
Beyond the preview
Go deeper on MOH_2020-11-04_009434.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2020-11-04_009434.